Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOncimmune Share News (ONC)

  • This share is currently suspended. It was suspended at a price of 1.2699
  • There is currently no data for ONC

Oncimmune News

AIM WINNERS & LOSERS: Elixirr meets guidance, in strong start to 2023
27 Feb 2023

AIM WINNERS & LOSERS: Elixirr meets guidance, in strong start to 2023

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

CORRECT: Oncimmune works with Siemens Healthineers on cancer therapy
20 Feb 2023

CORRECT: Oncimmune works with Siemens Healthineers on cancer therapy

(Correcting headquarters location of Siemens Healthineers.)

Oncimmune enters collaboration with Siemens Healthineers
17 Feb 2023

Oncimmune enters collaboration with Siemens Healthineers

(Sharecast News) - Immunodiagnostics specialist Oncimmune announced a collaboration with Siemens Healthineers on Friday, to improve malignancy risk as...

AIM WINNERS & LOSERS: Purplebricks drops as turnaround plan continues
17 Feb 2023

AIM WINNERS & LOSERS: Purplebricks drops as turnaround plan continues

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Oncimmune partners with Siemens Healthineers on lung cancer therapy
17 Feb 2023

Oncimmune partners with Siemens Healthineers on lung cancer therapy

(Alliance News) - Oncimmune Holdings PLC on Friday said that it has collaborated with Siemens Healthineers AG, a Frankfurt-based medical technology co...

TRADING UPDATES: FBD loses CFO; Eqtec wins GBP 2 million loan facility
9 Dec 2022

TRADING UPDATES: FBD loses CFO; Eqtec wins GBP 2 million loan facility

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: